Ophthotech's Revenue Finance Round

Ophthotech raised a round of funding on May 29, 2013. Investors include Novo Holdings.

Ophthotech is a biopharmaceutical company focusing on discovering, developing and commercializing therapies for the treatment of major ophthalmic diseases. Ophthotech's lead compound Fovista (previous…

Articles about Ophthotech's Revenue Finance Round: